Study of pharmacological activity of dry extract of sakhalin willow shoots against the background of experimental thrombophlebitis
Open Access
- 31 August 2023
- journal article
- research article
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4(44),p. 97-103
Abstract
The aim. The objective of the research was to study the pharmacological activity of dry extract of Sakhalin willow shoots – DEWS against the background of experimental thrombophlebitis. Materials and methods. Dry extract of Sakhalin willow shoots (DEWS) was the object matter of the present research and served as a therapeutic and prophylactic agent. In the experiment conducted, rabbits weighing 2.0 – 2.5 kg were used. The animals were divided into three groups. Group 1 was a control group; group 2 were animals that had been intragastrically injected with DEWS at a dose of 30 mg/kg prior to modelling thrombophlebitis; group 3 similarly received Eskuvit 20 mg/kg as a reference drug – pills (JSC Halychpharm, Ukraine). The dose for animals was recalculated, taking into account body weight according to the Rybolovlev method. Experimental thrombophlebitis was caused by injecting an intravenous solution of 2 % lugol at a dose of 0.1 ml into the marginal vein of the ear. Statistical data processing was carried out using the Statistica for Windows 11.0 program based on variance analysis for repeated measurement data using the Mann-Whitney criteria at a probability level of p<0.05. Results. Against the background of the development of experimental thrombophlebitis in rabbits, the development of thrombosis of the ear vein and the inflammatory process of adjacent tissues were observed. The inflammatory process was accompanied by pronounced hyperemia and oedema. Prophylactic administration of DEWS for 6 days contributed to a decrease in the inflammatory process already on the 5th day of observation. The area of the injured area was 20 % smaller than in the control pathology group. The therapeutic and prophylactic effect of herbal medicine can be explained by the content of flavonoids and salicylates in its composition. Eskuvit showed a less pronounced thrombolytic effect in terms of its influence on thrombosis and thrombolysis. Conclusions. The administration of DEWS in the therapeutic and prophylactic regimen at a dose of 30 mg/kg has a pronounced anti-inflammatory, thrombolytic and venoprotective effect in experimental peripheral venous thrombophlebitis in rabbits. The results of the studies obtained allow us to recommend DEWS as a promising venoprotective agent with thrombolytic activityKeywords
This publication has 9 references indexed in Scilit:
- Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro SystemsInternational Journal of Molecular Sciences, 2021
- Macro- and Microelements in the Branches of some Salix Genus Species in the Flora of UkraineInternational Journal of Pharmaceutical Research and Allied Sciences, 2020
- Current Insights on the Etiology and Pathogenesis of Venous Thrombosis: Virchow's Triad RevisionJournal of Venous Disorders, 2019
- Obesity and Chronic Venous Insufficiency: from Risk Factors to PathogenesisJournal of Venous Disorders, 2019
- THE STUDY OF THE FLAVONOIDS AND ANTIDEPRESSANT ACTIVITY OF THE LEAVES AND LIQUID EX-TRACT OF CRATAEGUS SUBMOLLISChemistry of plant raw material, 2018
- Evaluation on Analgesic and Anti‐Inflammatory Activities of Total Flavonoids from Juniperus sabinaEvidence-Based Complementary and Alternative Medicine, 2018
- Long‐term risk of venous thromboembolism recurrence after isolated superficial vein thrombosisJournal of Thrombosis and Haemostasis, 2017
- Benefit of anticoagulation for the treatment of lower extremity superficial venous thrombosisJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2015
- Progression in venous pathologyPhlebology: The Journal of Venous Disease, 2015